Aurobindo Pharma: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | Value Research

Aurobindo Pharma: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

This is to inform you that Mr. S. Subramanian Chief Financial Officer along with other executives of the Company will be interacting in person with various investors as part of Goldman Sachs - India Pharma and Healthcare Tour on Wednesday September 28 2022 between 9:00 am - 10:00 am (IST) at our Corporate Office at Galaxy Floors: 22-24 Plot No.1 Survey No.83/1 Hyderabad Knowledge City Raidurg Panmaktha Ranga Reddy District Hyderabad - 500 032.

Click here to view PDF


Other Categories